DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
KEY PRODUCTS
Reset all filters
01 1Dr. Reddy's Laboratories
Reset all filters
01 1DL-NAPROXEN
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35230
Submission : 2020-10-07
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is DL-NAPROXEN, with a corresponding US DMF Number 35230.
Remarkably, this DMF maintains an Active status since its submission on October 07, 2020, highlighting commitment to regulatory compliance.